Wnt signaling and Dupuytren's disease.

Wnt signaling and Dupuytren's disease.

BACKGROUND: Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pa...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Dolmans, G, Werker, P, Hennies, H, Furniss, D, Festen, E, Franke, L, Becker, K, van der Vlies, P, Wolffenbuttel, B, Tinschert, S, Toliat, MR, Nothnagel, M, Franke, A, Klopp, N, Wichmann, H, Nürnberg, P, Giele, H, Ophoff, R, Wijmenga, C
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registros relacionados

Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
por: Kerstin Becker, et al.
Publicado em: (2016-01-01)

A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis
por: Ng, M, et al.
Publicado em: (2017)

Genome-wide association scan of Dupuytren's disease.
por: Furniss, D, et al.
Publicado em: (2011)

Sibling recurrence risk in Dupuytren's disease.
por: Capstick, R, et al.
Publicado em: (2013)

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
por: Sophie A. Riesmeijer, et al.
Publicado em: (2024-01-01)

Surgery for Dupuytren's contracture of the fingers.
por: Rodrigues, J, et al.
Publicado em: (2015)

A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren’s disease
por: Riesmeijer, S, et al.
Publicado em: (2019)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
por: Major, M, et al.
Publicado em: (2019)

The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales.
por: Khan, A, et al.
Publicado em: (2004)

Is Dupuytren’s disease really a “disease of the Vikings”?
por: Ng, M, et al.
Publicado em: (2019)

Imaging for Dupuytren disease: a systematic review of the literature
por: Sanne Molenkamp, et al.
Publicado em: (2019-05-01)

Reduced WNT4 expression in normal skin fibroblasts leads to ‘Dupuytren-like’ changes in the transcriptome
por: Aoife O'Brien, et al.
Publicado em: (2024-09-01)

Commentary on Larson et al. Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
por: Furniss, D
Publicado em: (2015)

Guillaume Dupuytren
por: Romina A Parquet
Publicado em: (2013-01-01)

Dupuytren’s disease
por: Richard Trèves
Publicado em: (2011-09-01)

Dupuytren's disease
por: Rames Mattar Junior
Publicado em: (2008-03-01)

Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3.
por: Furniss, D, et al.
Publicado em: (2007)

Treatment for Dupuytren's disease
por: Nanchahal, J, et al.
Publicado em: (2013)

Paediatric Dupuytren's disease
por: Pradeoth Mukundan Korambayil, et al.
Publicado em: (2011-09-01)

Enfermedad de Dupuytren
por: J. M. Arandes Renú
Publicado em: (2010-11-01)

Enfermedad de Dupuytren
por: Jorge Badilla-Mora, et al.
Publicado em: (2004-10-01)

Enfermedad de Dupuytren
por: Jorge Badilla-Mora, et al.
Publicado em: (2004-10-01)

Enfermedad de Dupuytren
por: Jorge de Vecchi, et al.
Publicado em: (2020-03-01)

Dupuytren’s disease. State of the art and therapeutic perspectives
por: F.P. Cantatore, et al.
Publicado em: (2011-09-01)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
por: Nataly Puerta Cavanzo, et al.
Publicado em: (2022-08-01)

Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
por: Nanchahal, J, et al.
Publicado em: (2022)

The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
por: Majeed, M, et al.
Publicado em: (2020)

Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study
por: Bendon, C, et al.
Publicado em: (2015)

Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema
por: Leung, N, et al.
Publicado em: (2015)

Outcomes of peripheral nerve schwannoma excision in NF2 patients are as good as in non-NF2 patients - a case-control study
por: Bendon, C, et al.
Publicado em: (2013)

Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis
por: Broekstra, DC, et al.
Publicado em: (2022)

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
por: Sandhya Ganesan, et al.
Publicado em: (2023-07-01)

The incidence and prevalence of Dupuytren’s disease in primary care: results from a text mining approach on registration data
por: Roel J. M. van Straalen, et al.
Publicado em: (2024-10-01)

Molecular genetics of Dupuytren’s contracture
por: Aissvarya, Shankar, et al.
Publicado em: (2024)

The molecular genetics of dupuytren disease
por: Ng, M
Publicado em: (2018)

The Hand Patient: Dupuytren's Contracture
por: U. Mennen
Publicado em: (2001-04-01)

Molecular genetics of Dupuytren’s contracture
por: Shankar Aissvarya, et al.
Publicado em: (2024-08-01)

Dupuytren’s Diathesis in an African Male
por: Richard Mbuva, et al.
Publicado em: (2016-07-01)

Needle Aponeurotomy for Dupuytren's Contracture
por: HS Cheng, et al.
Publicado em: (2008-04-01)

Heterotopic ossification in Dupuytren's disease: clinical and histological significance.
por: Sadideen, H, et al.
Publicado em: (2011)